OVERVIEW

The Medical Exoskeleton Market is expected to reach USD 1464 million by 2026, growing at a CAGR of 37.4% during the forecast period. The major drivers include rising number of people across the world with lower limb disorders is bolstering the need or mobility aid and assistive medical devices. The growing morbidity and health burden of disorders such as cerebral embolisms and spinal cord injuries is a notable factor driving the demand for medical exoskeleton. The need is substantial among geriatrics in all major regions of the globe. The growing demand for innovative rehabilitation approaches has posited increasing focus of the medical community on medical exoskeleton, thus fueling the rapid expansion of the global market. A detailed report on the impact of COVID-19 on the Medical Exoskeleton Market is included in the report for 2021 and beyond.

TABLE OF CONTENT

• 1 Global Medical Exoskeleton Market
  • 1.1 Study Objectives
  • 1.2 Market Definition
  • 1.3 Study Scope
    • 1.3.1 Markets Covered
    • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Medical Exoskeleton Market – Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Medical Exoskeleton Market – Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Medical Exoskeleton Market – Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis – Top 10 companies

• 6 Global Medical Exoskeleton Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Medical Exoskeleton Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Medical Exoskeleton Market – By Component (Market Size – & million/billion)
  • 8.1 Hardware
  • 8.2 Sensors
  • 8.3 Actuators
  • 8.4 Power Sources
  • 8.5 Control Systems
  • 8.6 Other Hardware Components
  • 8.7 Software

• 9 Global Medical Exoskeleton Market - By Type
  • 9.1 Powered Exoskeletons
  • 9.2 Passive Exoskeletons

• 10 Global Medical Exoskeleton Market - By Extremity
  • 10.1 Upper Extremity Medical Exoskeletons
  • 10.2 Lower Extremity Medical Exoskelet

• 11 Global Medical Exoskeleton Market - By Mobility
  • 11.1 Stationary Exoskeletons
  • 11.2 Mobile Exoskeletons

• 12 Global Medical Exoskeleton Market – By Geography (Market Size – & million/billion)
  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 U.K
    • 12.3.2 Germany
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia-Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 South Korea
    • 12.4.5 Rest of APAC
  • 12.5 Rest of the World
    • 12.5.1 South America
    • 12.5.2 Middle East
    • 12.5.3 Africa

• 13 Global Medical Exoskeleton Market – Entropy
  • 13.1 New product launches
  • 13.2 M&A's, collaborations, JVs and partnerships

• 14 Global Medical Exoskeleton Market Company Profile (Key Players)
  • 14.1 Market Share, Company Revenue, Products, M&A, Developments
  • 14.2 Cyberdyne
  • 14.3 Ekso Bionics Holdings
  • 14.4 Rewalk Robotics
  • 14.5 Bionik Laboratories
  • 14.6 Rex Bionics
  • 14.7 Hocoma AG (A Subsidiary of DIH Technologies)
  • 14.8 Wearable Robotics
  • 14.9 Parker Hannifin
  • 14.10 B-Temia
  • 14.11 Bioness
  • 14.12 Company 11 & more

• 15 Global Medical Exoskeleton Market - Appendix
  • 15.1 Sources
  • 15.2 Abbreviations